RRML - Molecular epidemiology and the clinical impact of carbapenemase-producing Enterobacterales isolates among adult patients: aspects from a Romanian non-teaching hospital
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2020): 75%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- June 2021 -
 
The evaluation of a diagnostic... 47
Prognostic value of serum lact... 20
The possibility of clinical us... 10
Romanian Review of Laboratory ... 9
Prevalence of ∆F508 cystic f... 9
Predictors associated with inc... 8
Essentials in the diagnosis of... 8
Platelets and Infections... 7
Evaluation of Plasma AA/DHA+EP... 7
Pseudohyponatremia and falsely... 7

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 28(4)/2020 DOI:10.2478/rrlm-2020-0035
XML
TXT

Research article

Molecular epidemiology and the clinical impact of carbapenemase-producing Enterobacterales isolates among adult patients: aspects from a Romanian non-teaching hospital

Annamária Főldes, Szabolcs Molnár, Doina-Veronica Bilca, Septimiu Toader Voidăzan, Edit Székely

Correspondence should be addressed to: Annamária Főldes

Abstract:

Introduction: A dramatic increase of infections induced by carbapenemase-producing Enterobacterales (CPE) has been registered worldwide. The aim of this study was to evaluate the molecular epidemiology and the clinical impact of CPE strains isolated from adult inpatients. Material and methods: A one-year, single-center, retrospective observational study including 34 consecutive patients with 37 non-duplicate CPE strains recovered from clinical specimens was accomplished. The Vitek 2 Compact, M.I.C.Evaluator strips, the modified carbapenem inactivation method (mCIM), and the combination disks test (KPC, MBL, OXA-48 Confirm kit, Rosco Diagnostica) were applied as phenotypic tests. A multiplex polymerase chain reaction (PCR) assay was used for detection of blaKPC, blaNDM, and blaOXA-48-like genes. The clonality was assessed with pulsed-field gel electrophoresis (PFGE). Results: Klebsiella pneumoniae (n=25) was the most frequent CPE encountered. The carbapenemase types were NDM (n=13), KPC (n=12), and OXA-48-like (n=12). Two distinct clonal clusters were identified among the 12 KPC positive strains. All CPE isolates exhibited non-susceptibility to carbapenems, cephalosporins, ciprofloxacin. Respiratory tract infections (n=16) and hospitalization in the intensive care unit (ICU) (n=14) were dominant. The most common comorbidity was congestive heart failure (n=11). Monotherapy was the main strategy adopted (n=15). Death occurred in 18 patients. Conclusions: Our analysis underscores the scarcity of antibiotic solutions and high mortality. Monotherapy for urinary tract infections (UTIs) is beneficial. Inter- or intrahospital dissemination of successful epidemic clones is proved. The adequate CPE infections control programs and antimicrobial policies are essential.

Keywords: carbapenemases, Enterobacterales, antimicrobial treatment, mortality

Received: 16.7.2020
Accepted: 11.10.2020
Published: 16.10.2020

 
  PDF Download full text PDF
(628 KB)
     
 
How to cite
Főldes A, Molnár S, Bilca DV, Voidăzan ST, Székely E. Molecular epidemiology and the clinical impact of carbapenemase-producing Enterobacterales isolates among adult patients: aspects from a Romanian non-teaching hospital. Rev Romana Med Lab. 2020;28(4):427-39. DOI:10.2478/rrlm-2020-0035